Abacavir Tablet, Film Coated
Product Images NDC 68084-021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Abacavir (NDC 68084-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

76267e0f Fa20 49ec E053 2991aa0a877a

FDA Label Image

Image 01

FDA Label Image

Image 02

Image 02
Abacavir Tablets USP is a prescription drug dispensed in packages of 30 tablets (3 x 10) under the name Axonly. Each film-coated tablet contains Abacaui Sufate USP equivalent to 300 mg of abacavi. The usual dosage range can be found in the package insert prescribing. The drug should be stored in a cool dry place and kept away from children. The package is distributed by American Health Packaging and must be accompanied by a medical guide and warning card for each patient.*
FDA Label Image

Image 04

Image 04
The text mentions a medication called Abacavir in a tablet form with a strength of 300mg. There are different dosages and batch numbers mentioned.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.